CMV vaccine candidate showed promising data in a Phase 1 trial

被引：0
|
作者：
不详
机构：
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2018年 / 14卷 / 07期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1545 / 1545
页数：1
相关论文
共 50 条
  • [21] Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects
    Adler, Stuart P.
    Lewis, Nicole
    Conlon, Anthony
    Christiansen, Mark P.
    Al-Ibrahim, Mohamed
    Rupp, Richard
    Fu, Tong-Ming
    Bautista, Oliver
    Tang, Huaping
    Wang, Dai
    Fisher, Alison
    Culp, Timothy
    Das, Rituparna
    Beck, Karen
    Tamms, Gretchen
    Musey, Luwy
    JOURNAL OF INFECTIOUS DISEASES, 2019, 220 (03): : 411 - 419
  • [22] A promising candidate for a universal influenza vaccine
    Isakova-Sivak, Irina
    Rudenko, Larisa
    LANCET INFECTIOUS DISEASES, 2023, 23 (12): : 1327 - 1329
  • [23] Promising Phase 2 data for a universal influenza vaccine
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (09) : 1958 - 1958
  • [24] Shingles vaccine candidate strongly immunogenic in a Phase 3 trial
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (08) : 1734 - 1734
  • [25] Universal influenza vaccine candidate is tested in a Phase 2 trial
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (06) : 1307 - 1307
  • [26] Chikungunya vaccine candidate advances to a Phase 2 clinical trial
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (11) : 2721 - 2721
  • [27] COMPREHENSIVE BIOMARKER ANALYSIS OF RESPONDERS AND NON-RESPONDERS IN A PHASE IIA TRIAL OF A CMV VACCINE IMMUNOTHERAPEUTIC CANDIDATE (VBI-1901)
    Wen, Patrick Y.
    Reardon, David A.
    Forst, Deborah
    Lee, Eudocia
    Daoud, Teresa
    Berthoud, Tamara
    Soare, Catalina
    Diaz-Mitoma, Francisco
    Anderson, David E.
    Lassman, Andrew
    Iwamoto, Fabio
    NEURO-ONCOLOGY, 2022, 24 : 62 - 62
  • [28] New promising vaccine candidate against norovirus
    Riedmann, Eva M.
    HUMAN VACCINES, 2011, 7 (06): : 595 - 595
  • [29] HVTN100 phase 1/2 vaccine trial results promising; phase 2b/3 trial to commence
    Harper, Kristin N.
    AIDS, 2017, 31 (02) : N1 - N2
  • [30] Clostridium difficile vaccine candidate successful in phase 1
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (10) : 2036 - 2036
12345